Viking Therapeutics’ stock rallies following early drug study data

Australia News News

Viking Therapeutics’ stock rallies following early drug study data
Australia Latest News,Australia Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Wallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.

Viking Therapeutics Inc.

shares rose in the extended session Tuesday after the biotech drug developer said data from an early stage clinical study showed its drug candidate reduced liver fat levels. Viking shares rose as much as 7% after hours, following a 0.4% decline to close the regular session at $10.27. The company said a Phase 1 dosing study of its drug candidate VK2735 “showed reductions in subjects’ liver fat content and plasma lipid levels” after 28 days of treatment, compared with a group given a placebo.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock movers: Ericsson, Nokia, Tempest Therapeutics, NetScout SystemsStock movers: Ericsson, Nokia, Tempest Therapeutics, NetScout SystemsEricsson, Nokia, ServisFirst Bancshares and NetScout Systems shares were active.
Read more »

Researchers unlock the potential of genetic glycoengineering to advance vaccines and therapeutics technologyResearchers unlock the potential of genetic glycoengineering to advance vaccines and therapeutics technologyA novel glycoengineering platform, created by the laboratory of Assistant Professor Chris Lok-To Sham from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), is poised to revolutionize future production of vaccines and therapeutics to fight infectious diseases.
Read more »

Runestone Revelation Hints The Most Famous Viking Was a WomanRunestone Revelation Hints The Most Famous Viking Was a WomanThe Best in Science News and Amazing Breakthroughs
Read more »

Voices of Discovery at Baldwin WallaceVoices of Discovery at Baldwin WallaceThe 'Voices of Discovery' include leading scientists, explorers and thought leaders who have left an indelible mark on the way we view the world. Tom Gruber, AI Product Developer & SIRI Co-creator, will present “How AI can enhance our memory, work and social lives.
Read more »

Wallace Shawn Critical of U.S. Response to Israel-Gaza ConflictWallace Shawn Critical of U.S. Response to Israel-Gaza ConflictThe 'Toy Story' and 'The Princess Bride' actor said Israel's retaliatory response following Hamas' terrorist attack is 'one of the most deliberate cruelties inflicted on a group of people that I can remember and that my own government has supported.'
Read more »



Render Time: 2025-03-01 00:21:13